We are live on ! Find out more
Mackenzie Financial

Mackenzie Financial Portfolio holdings

AUM $83.3B
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
-13.43%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$62.4B
AUM Growth
-$12.1B
Cap. Flow
+$109M
Cap. Flow %
0.18%
Top 10 Hldgs %
22.29%
Holding
1,589
New
182
Increased
754
Reduced
502
Closed
132

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$282M
2
J icon
Jacobs Solutions
J
+$187M
3
TU icon
Telus
TU
+$170M
4
SHEL icon
Shell
SHEL
+$166M
5
MCD icon
McDonald's
MCD
+$132M

Sector Composition

Rank Sector Weight
1 Financials 22.28%
2 Technology 16.39%
3 Industrials 12.25%
4 Healthcare 10.92%
5 Energy 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MVST icon
1426
Microvast
MVST
$273M
$26K ﹤0.01%
+11,670
New +$50.1K
FIRY
1427
Firy Inc
FIRY
$146M
$26K ﹤0.01%
+1,040
New +$40.6K
PVLA
1428
Palvella Therapeutics
PVLA
$2.04B
$26K ﹤0.01%
+171
New +$31.2K
INO icon
1429
Inovio Pharmaceuticals
INO
$52.7M
$25K ﹤0.01%
1,212
+263
+28% +$7.41K
NAT icon
1430
Nordic American Tanker
NAT
$1.39B
$25K ﹤0.01%
+11,616
New +$27.8K
YARW
1431
Yarrow Bioscience, Inc. Common Stock
YARW
$22.7M
$25K ﹤0.01%
73
DM
1432
DELISTED
Desktop Metal, Inc.
DM
$25K ﹤0.01%
+1,154
New +$33.8K
XXII
1433
22nd Century Group
XXII
$1.36M
0
NEUE
1434
DELISTED
NeueHealth
NEUE
$24K ﹤0.01%
167
-14
-8% -$2.04K
AMRS
1435
DELISTED
Amyris Inc.
AMRS
$23K ﹤0.01%
+12,365
New +$36.4K
CYCN icon
1436
Cyclerion Therapeutics
CYCN
$14.8M
$22K ﹤0.01%
2,046
+781
+62% +$11.2K
SENS icon
1437
Senseonics Holdings Inc
SENS
$258M
$22K ﹤0.01%
1,068
+308
+41% +$8.03K
ONCT
1438
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$22K ﹤0.01%
+997
New +$22.2K
CORZ
1439
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$22K ﹤0.01%
+14,987
New +$68.9K
UP icon
1440
Wheels Up
UP
$214M
$21K ﹤0.01%
+55
New +$29.4K
CENN icon
1441
Cenntro
CENN
$8.21M
$19K ﹤0.01%
+21
New +$22.2K
ORIO
1442
Orion Digital Corp
ORIO
$15.4M
$19K ﹤0.01%
7,641
-531
-6% -$2.52K
INFI
1443
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$17K ﹤0.01%
+27,182
New +$20.9K
BBIG
1444
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$17K ﹤0.01%
+622
New +$20.9K
RIDE
1445
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$17K ﹤0.01%
+724
New +$23.3K
GTE icon
1446
Gran Tierra Energy
GTE
$242M
$16K ﹤0.01%
1,395
AKBA icon
1447
Akebia Therapeutics
AKBA
$349M
$15K ﹤0.01%
42,792
+20,929
+96% +$8.78K
HIPO icon
1448
Hippo Holdings
HIPO
$817M
$15K ﹤0.01%
+688
New +$25.4K
URG
1449
Ur-Energy
URG
$481M
$14K ﹤0.01%
+12,989
New +$17.3K
WGS icon
1450
GeneDx Holdings
WGS
$1.96B
$14K ﹤0.01%
+325
New +$22K

Similar funds

Mackenzie Financial's Q2 2022 Portfolio in Review

As of Q2 2022, Mackenzie Financial held 1,589 positions worth $62.4B, down 16% from $74.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Mackenzie Financial's Q2 2022 filing shows 182 new, 754 increased, 502 reduced and 132 closed positions. Its largest new stake was Shell: 2,958,407 shares worth $155M. The largest sale was Equifax, an estimated $365M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Technology and Industrials.

  • Mackenzie Financial's largest Q2 2022 buy was Shell: 2,958,407 shares worth $155M.
  • Mackenzie Financial added most to Linde in Q2 2022, an estimated $282M increase.
  • Mackenzie Financial's biggest Q2 2022 reduction was Equifax, cutting an estimated $365M.
  • Mackenzie Financial fully exited Vertiv in Q2 2022, selling an estimated $27.3M.
  • Mackenzie Financial's ten largest holdings make up 22% of its $62.4B portfolio in Q2 2022.
  • Mackenzie Financial opened 182 new positions and closed 132 in Q2 2022.
  • Mackenzie Financial's portfolio value fell 16% quarter-over-quarter to $62.4B.

Based on Mackenzie Financial's 13F filing for Q2 2022, filed 10 Aug 2022.